SCHEMBL19600434

SCHEMBL19600434

c1cnc2c(-c3ccc4c5c(cccc35)Oc3cc(-c5cc6c7ccccc7ccc6c6ccccc56)ccc3-4)cccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.36
MAPK1 P28482 1/20 0.36
ATM Q13315 1/20 0.36
AVPR2 P30518 1/20 0.35
AVPR1A P37288 1/20 0.35
BRD4 O60885 1/20 0.34
METAP2 P50579 1/20 0.33
MAPT P10636 2/20 0.33
GAA P10253 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
LMNA P02545 3/20 0.33
CCR1 P32246 2/20 0.33
CCR5 P51681 2/20 0.33
CCR8 P51685 2/20 0.33
CYP3A4 P08684 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GMNN O75496 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19600413 0.93 KDM4E (0.39) KDM4EMAPK1ATMAVPR2AVPR1A
SCHEMBL17265393 0.89 HSD17B10 (0.37) KDM4EMAPK1ATMAVPR2AVPR1A
SCHEMBL19600428 0.82 MAPK1 (0.40) KDM4EMAPK1ATMMAPTHSD17B10
SCHEMBL17265398 0.82 BRD4 (0.36) KDM4EMAPK1ATMBRD4METAP2
SCHEMBL17120177 0.82 KDM4E (0.34) KDM4EMAPK1ATMAVPR2AVPR1A
SCHEMBL17120216 0.82 FABP1 (0.39) KDM4EMAPK1ATMAVPR2AVPR1A
SCHEMBL17120223 0.81 FABP1 (0.39) KDM4EMAPK1ATMAVPR2AVPR1A
SCHEMBL19600435 0.80 MAPK1 (0.40) KDM4EMAPK1ATMMAPTHSD17B10
SCHEMBL17120192 0.80 KDM4E (0.33) KDM4EMAPK1ATMBRD4MAPT
SCHEMBL17265419 0.79 ERN1 (0.36) KDM4EMAPK1ATMHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10573825-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-25 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10573825-B2 Compound and organic light-emitting device including the same CRY1, CRY2, AOX1 KDM4E 2074/4885MAPK1 2174/4885ATM 2475/4885
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, AOX1 KDM4E 2074/4885MAPK1 2174/4885ATM 2475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.